Log in to save to my catalogue

Effectiveness of asfotase alfa for treatment of adults with hypophosphatasia: results from a global...

Effectiveness of asfotase alfa for treatment of adults with hypophosphatasia: results from a global...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_37968c05241044a7ae66037fae804ebb

Effectiveness of asfotase alfa for treatment of adults with hypophosphatasia: results from a global registry

About this item

Full title

Effectiveness of asfotase alfa for treatment of adults with hypophosphatasia: results from a global registry

Publisher

England: BioMed Central Ltd

Journal title

Orphanet journal of rare diseases, 2024-03, Vol.19 (1), p.109-109, Article 109

Language

English

Formats

Publication information

Publisher

England: BioMed Central Ltd

More information

Scope and Contents

Contents

Hypophosphatasia (HPP) is a rare inherited disease caused by deficient activity of tissue-nonspecific alkaline phosphatase. Many adults with HPP have a high burden of disease, experiencing chronic pain, fatigue, limited mobility, and dental issues, contributing to decreased health-related quality of life (HRQoL). HPP may be treated with the enzyme...

Alternative Titles

Full title

Effectiveness of asfotase alfa for treatment of adults with hypophosphatasia: results from a global registry

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_37968c05241044a7ae66037fae804ebb

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_37968c05241044a7ae66037fae804ebb

Other Identifiers

ISSN

1750-1172

E-ISSN

1750-1172

DOI

10.1186/s13023-024-03048-6

How to access this item